Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) Sees Significant Increase in Short Interest

Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) saw a large growth in short interest in the month of February. As of February 13th, there was short interest totaling 16,137,050 shares, a growth of 35.6% from the January 29th total of 11,896,551 shares. Based on an average daily trading volume, of 11,713 shares, the short-interest ratio is currently 1,377.7 days. Based on an average daily trading volume, of 11,713 shares, the short-interest ratio is currently 1,377.7 days.

Genomma Lab Internacional Stock Performance

Genomma Lab Internacional stock remained flat at $1.00 during mid-day trading on Tuesday. Genomma Lab Internacional has a fifty-two week low of $0.93 and a fifty-two week high of $1.43. The firm has a 50 day simple moving average of $1.03 and a two-hundred day simple moving average of $1.05.

Genomma Lab Internacional Company Profile

Genomma Lab Internacional, SAB. de C.V. is a Mexico City–based consumer healthcare company that develops, markets and distributes over-the-counter (OTC) pharmaceuticals, personal care products and beauty solutions. Since its founding in 1996, the firm has built a diversified portfolio encompassing topical analgesics, cold and flu remedies, digestive health treatments, skin and hair care lines, and nutritional supplements. Its product mix blends proprietary brands with licensed formulas, targeting everyday wellness and self-care needs.

The company’s growth strategy hinges on intensive marketing campaigns, including television infomercials, digital advertising and direct‐to‐consumer promotions.